Information:
Fel:
ID
14231
Beskrivning
Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain; ODM derived from: https://clinicaltrials.gov/show/NCT00287248
Länk
https://clinicaltrials.gov/show/NCT00287248
Nyckelord
Versioner (1)
- 2016-04-05 2016-04-05 -
Uppladdad den
5 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Alzheimer Disease NCT00287248
Eligibility Alzheimer Disease NCT00287248
- StudyEvent: Eligibility
Similar models
Eligibility Alzheimer Disease NCT00287248
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
age
Item
the participant is 50 years or older.
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
written informed consent is obtained.
boolean
C0021430 (UMLS CUI [1])
alzheimers disease
Item
participants have a clinical diagnosis of alzheimer's disease based on national institute of neurological and communicative disorders and stroke/alzheimer's disease and related disorders association (nincds/adra) criteria.
boolean
C0002395 (UMLS CUI [1])
mini mental status exam score
Item
mini-mental status exam score > 16 and < 25.
boolean
C2225229 (UMLS CUI [1])
alzheimers disease
Item
patients have a diagnosis of probable ad for < 3 years prior to screening.
boolean
C0002395 (UMLS CUI [1])
neurodegenerative disease; Parkinson Disease; lewy body dementia; cerebrovascular disease
Item
the subject has signs or symptoms of another neurodegenerative disease including parkinson's disease, diffuse lewy body dementia, or history of significant cerebrovascular disease.
boolean
C0524851 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
C0752347 (UMLS CUI [3])
C0007820 (UMLS CUI [4])
C0030567 (UMLS CUI [2])
C0752347 (UMLS CUI [3])
C0007820 (UMLS CUI [4])
iodine allergy
Item
subjects with an iodine allergy.
boolean
C0571818 (UMLS CUI [1])
psychiatric illness
Item
the subject has a clinically significant clinical laboratory value and/or medical or psychiatric illness.
boolean
C0004936 (UMLS CUI [1])
Compliance behavior Limited Comorbidity; drug absorption; gastrointestinal surgery
Item
the subject has any disorder that may interfere with drug absorption distribution, metabolism, or excretion (including gastrointestinal surgery).
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0678745 (UMLS CUI [2])
C0524722 (UMLS CUI [3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0678745 (UMLS CUI [2])
C0524722 (UMLS CUI [3])
thyroid disease; gastrointestinal disease; cardiovascular disease; hepatic disease; renal disease; hematologic disease; neoplastic disease; psychiatric disorder
Item
the subject has evidence of clinically significant thyroid disease, gastrointestinal, cardiovascular, hepatic, renal, hematologic, neoplastic, endocrine, neurologic, immunodeficiency, pulmonary, or other medical or psychiatric disorder.
boolean
C0040128 (UMLS CUI [1])
C0017178 (UMLS CUI [2])
C0007222 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0022658 (UMLS CUI [5])
C0018939 (UMLS CUI [6])
C1882062 (UMLS CUI [7])
C0004936 (UMLS CUI [8])
C0017178 (UMLS CUI [2])
C0007222 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0022658 (UMLS CUI [5])
C0018939 (UMLS CUI [6])
C1882062 (UMLS CUI [7])
C0004936 (UMLS CUI [8])
investigational drug
Item
the subject has received an investigational drug within 60 days before the screening visit.
boolean
C0013230 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])